Richter K K, Fagerhol M K, Carr J C, Winkler J M, Sung C C, Hauer-Jensen M
Department of Surgery, University of Arkansas for Medical Sciences, Little Rock, USA.
Radiat Oncol Investig. 1997;5(6):275-82. doi: 10.1002/(SICI)1520-6823(1997)5:6<275::AID-ROI3>3.0.CO;2-V.
Inflammatory cells are involved in the pathogenesis of tissue injury through release of cytokines and biologically active compounds. This study used a novel, noninvasive method to assess the association between granulocyte transmigration and structural and molecular changes in radiation enteropathy. A 4 cm loop of rat small intestine was exposed to 0, 2.8, 12, or 23 Gy localized irradiation. Feces was collected in metabolic cages before and 3, 7, 14, 28, and 42 days after irradiation. Granulocyte marker protein (GMP) was measured in buffer extracts of feces by enzyme-linked immunosorbent assay (ELISA). Irradiated and shielded intestine were procured at 2 and 26 weeks and assessed for histopathologic injury [radiation injury score (RIS)], ED-2 positive macrophages, and interleukin-1 alpha (IL-1 alpha) positive cells. Irradiated intestine exhibited characteristic histopathologic alterations and increased numbers of macrophages and IL-1 alpha positive cells. There was a highly significant dose-dependent increase in post-radiation GMP (P < 0.0001). Maximal GMP excretion occurred 3-7 days after irradiation. Six weeks after irradiation, GMP excretion had returned to normal in the 2.8 and 12 Gy groups, but was still 3.5 times higher in the 23 Gy group than in controls. The associations between early GMP excretion and RIS and fibrosis at 26 weeks were highly significant (P < 0.001 and P < 0.0001, respectively). Post-radiation granulocyte transmigration is dose-dependent and correlates with structural and molecular changes, as well as with subsequent chronic injury. The GMP assay is a sensitive, non-invasive indicator of acute intestinal radiation injury and a promising biological predictor of chronic toxicity. Our data underscore the importance of consequential mechanisms in radiation enteropathy.
炎症细胞通过释放细胞因子和生物活性化合物参与组织损伤的发病机制。本研究采用一种新型的非侵入性方法来评估粒细胞迁移与放射性肠病的结构和分子变化之间的关联。将大鼠小肠的4厘米肠袢暴露于0、2.8、12或23 Gy的局部照射。在照射前以及照射后3、7、14、28和42天,在代谢笼中收集粪便。通过酶联免疫吸附测定(ELISA)测量粪便缓冲提取物中的粒细胞标记蛋白(GMP)。在2周和26周时获取照射和未照射的肠道,评估组织病理学损伤[放射损伤评分(RIS)]、ED-2阳性巨噬细胞和白细胞介素-1α(IL-1α)阳性细胞。照射后的肠道表现出特征性的组织病理学改变,巨噬细胞和IL-1α阳性细胞数量增加。辐射后GMP呈高度显著的剂量依赖性增加(P < 0.0001)。照射后3 - 7天出现最大GMP排泄量。照射6周后,2.8 Gy和12 Gy组的GMP排泄已恢复正常,但23 Gy组仍比对照组高3.5倍。早期GMP排泄与26周时的RIS和纤维化之间的关联高度显著(分别为P < 0.001和P < 0.0001)。辐射后粒细胞迁移是剂量依赖性的,与结构和分子变化以及随后的慢性损伤相关。GMP测定是急性肠道辐射损伤的敏感、非侵入性指标,也是慢性毒性的有前景的生物学预测指标。我们的数据强调了放射性肠病中后续机制的重要性。